Literature DB >> 21441243

Chronic intrathecal infusion of gabapentin prevents nerve ligation-induced pain in rats.

L-C Chu1, M-L Tsaur, C-S Lin, Y-C Hung, T-Y Wang, C-C Chen, J-K Cheng.   

Abstract

BACKGROUND: Gabapentin is an anticonvulsant and adjuvant analgesic. It is effective in several pain studies. Neuropathic pain is the most difficult type of pain to treat. In this study, we examined if intrathecal gabapentin could prevent nerve injury-induced pain.
METHODS: Under isoflurane anaesthesia, male Sprague-Dawley rats (200-250 g) underwent right L5/6 spinal nerve ligation and placement of an intrathecal catheter connected to an infusion pump. After surgery, intrathecal saline or gabapentin (20 µg h(-1)) was given for 7 days (n=8 per group). The right hind paw withdrawal threshold to von Frey filament stimuli and withdrawal latency to radiant heat were determined before (baseline) and once daily for 7 days after surgery. Haematoxylin and eosin and toluidine blue staining were used to evaluate the neurotoxicity of gabapentin (40 µg h(-1)).
RESULTS: Seven days after nerve ligation, the affected paw withdrawal threshold and latency of saline-treated rats decreased from the baseline 11.7 (11.7-22.2) [median (inter-quartile range)] to 1.6 (0.9-3.2) g and 10.8 (10.5-11.2) to 4.3 (4.2-7) s, respectively. Rats receiving gabapentin (20 µg h(-1)) had higher withdrawal threshold [9.9 (9.9-19.3) g] and latency [11.5 (9.7-11.9) s] on day 7 after ligation. No obvious histopathological change or growth retardation was detected after intrathecal gabapentin (40 µg h(-1)) infusion.
CONCLUSIONS: We showed a preventative effect of intrathecal gabapentin on the development of nerve injury-induced mechanical allodynia and thermal hyperalgesia. Our data suggest that continuous intrathecal gabapentin may be considered as an alternative for the prevention of nerve injury-induced pain.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21441243     DOI: 10.1093/bja/aer063

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  7 in total

1.  Gabapentinoid Insensitivity after Repeated Administration is Associated with Down-Regulation of the α(2)δ-1 Subunit in Rats with Central Post-Stroke Pain Hypersensitivity.

Authors:  Yan Yang; Fei Yang; Fan Yang; Chun-Li Li; Yan Wang; Zhen Li; Yun-Fei Lu; Yao-Qing Yu; Han Fu; Ting He; Wei Sun; Rui-Rui Wang; Jun Chen
Journal:  Neurosci Bull       Date:  2016-01-19       Impact factor: 5.203

Review 2.  Current and Future Issues in the Development of Spinal Agents for the Management of Pain.

Authors:  Tony L Yaksh; Casey J Fisher; Tyler M Hockman; Ashley J Wiese
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

3.  The effects of opioid receptor antagonists on electroacupuncture-produced anti-allodynia/hyperalgesia in rats with paclitaxel-evoked peripheral neuropathy.

Authors:  Xianze Meng; Yu Zhang; Aihui Li; Jiajia Xin; Lixing Lao; Ke Ren; Brian M Berman; Ming Tan; Rui-Xin Zhang
Journal:  Brain Res       Date:  2011-08-07       Impact factor: 3.252

4.  Gabapentin prevents oxaliplatin-induced central sensitization in the dorsal horn neurons in rats.

Authors:  Teng Ruyang; Zhao Yang; Feng Wei
Journal:  Iran J Basic Med Sci       Date:  2015-05       Impact factor: 2.699

5.  Analgesic effect of intrathecal gabapentin in a rat model of persistent muscle pain.

Authors:  Tae-Wook Kang; Min Kyun Sohn; Noh Kyoung Park; Sang Hyung Ko; Kyoung Jin Cho; Jaewon Beom; Sangkuk Kang
Journal:  Ann Rehabil Med       Date:  2014-10-30

6.  Effect of two-week continuous epidural administration of 2% lidocaine on mechanical allodynia induced by spinal nerve ligation in rats.

Authors:  Yuseon Cheong; Minsoo Kim; Namyoong Kim; Byeongmun Hwang
Journal:  Anesth Pain Med (Seoul)       Date:  2020-07-31

7.  Preemptive perineural bupivacaine attenuates the maintenance of mechanical and cold allodynia in a rat spinal nerve ligation model.

Authors:  John L Clifford; Alberto Mares; Jacob Hansen; Dayna L Averitt
Journal:  BMC Anesthesiol       Date:  2015-10-06       Impact factor: 2.217

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.